MicroRNAs and Prognosis in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

1,432

Participants

Timeline

Start Date

October 28, 2014

Primary Completion Date

October 28, 2018

Study Completion Date

November 28, 2019

Conditions
Breast Cancer FemaleMetastases Breast
Interventions
DIAGNOSTIC_TEST

miRNA targeted analysis on breast cancer tissues

Total RNA is extracted from tissue sample and selected miRNA quantified by PCR based relative quantification method (QPCR) with a standard curve.

DIAGNOSTIC_TEST

miRNA targeted analysis on plasma samples

miRNAs extracted from plasma samples are analysed by QPCR and/or ddPCR .

DIAGNOSTIC_TEST

miRNA profiling of breast cancer tissues

Selected samples from the retrospective cohort are profiled for miRNA expression by using GeneChip® miRNA 4.0 Array.

Trial Locations (1)

71013

Casa sollievo della Sofferenza IRCCS, San Giovanni Rotondo

All Listed Sponsors
lead

Casa Sollievo della Sofferenza IRCCS

OTHER

NCT06555354 - MicroRNAs and Prognosis in Breast Cancer | Biotech Hunter | Biotech Hunter